Strides Pharma Science has reported results for second quarter ended September 30, 2019.
The company has reported net profit of Rs 47 crore for the quarter under review as against net loss of Rs 14.30 crore for the same quarter in the previous year. Total income of the company increased by 27.54% at Rs 457.61 crore for Q2FY20 as compared Rs 358.79 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported net profit of Rs 141.91 crore for the quarter under review as against net loss of Rs 8.70 crore for the same quarter in the previous year. Total income of the company increased by 37.51% at Rs 728.08 crore for Q2FY20 as compared Rs 529.46 crore for the corresponding quarter previous year.
